STAT3 and neoplasm: The skewed anti-inflammatory gene response elicited by prolonged Stat3 activation in myeloid cells, on the other hand, curbs the immune system's anti-tumour response, while excessive Stat3 activation in inflammatory Th17 T-cells further fuels tumour growth and angiogenesis.